OGT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.355800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.897400E-01
Normal-vs-Stage2
4.432400E-01
Normal-vs-Stage3
3.564600E-01
Normal-vs-Stage4
2.940800E-01
Stage1-vs-Stage2
4.343400E-01
Stage1-vs-Stage3
2.269800E-02
Stage1-vs-Stage4
3.977800E-01
Stage2-vs-Stage3
1.403610E-01
Stage2-vs-Stage4
6.444800E-01
Stage3-vs-Stage4
4.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.388600E-01
Normal-vs-AfricanAmerican
4.279000E-01
Normal-vs-Asian
4.062000E-01
Caucasian-vs-AfricanAmerican
7.904600E-01
Caucasian-vs-Asian
3.869600E-01
AfricanAmerican-vs-Asian
7.273600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.401400E-01
Normal-vs-Female
4.316400E-01
Male-vs-Female
6.612600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.867400E-01
Normal-vs-Age(41-60Yrs)
4.596800E-01
Normal-vs-Age(61-80Yrs)
4.255600E-01
Normal-vs-Age(81-100Yrs)
4.160600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.422000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.541600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.956200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.209180E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.584400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.850600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.437200E-01
Normal-vs-Daily Drinker
4.304000E-01
Normal-vs-Weekly Drinker
4.304600E-01
Normal-vs-Occasional Drinker
4.490400E-01
Normal-vs-Social Drinker
4.702400E-01
Non Drinker-vs-Daily Drinker
7.014400E-01
Non Drinker-vs-Weekly Drinker
7.439600E-01
Non Drinker-vs-Occasional Drinker
9.197000E-01
Non Drinker-vs-Social Drinker
5.470000E-01
Daily Drinker-vs-Weekly Drinker
9.785800E-01
Daily Drinker-vs-Occasional Drinker
6.834400E-01
Daily Drinker-vs-Social Drinker
3.458800E-01
Weekly Drinker-vs-Occasional Drinker
7.346000E-01
Weekly Drinker-vs-Social Drinker
4.521200E-01
Occasional Drinker-vs-Social Drinker
6.877800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.470390E-01
Normal-vs-Grade 2
2.464200E-02
Normal-vs-Grade 3
3.742500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.063000E-01
Grade 1-vs-Grade 3
2.014800E-01
Grade 1-vs-Grade 4
1.470390E-01
Grade 2-vs-Grade 3
3.017800E-01
Grade 2-vs-Grade 4
2.464200E-02
Grade 3-vs-Grade 4
3.742500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.311000E-01
Normal-vs-NonDiabetic
4.321800E-01
Diabetic-vs-NonDiabetic
9.470200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.401600E-01
Normal-vs-NoPancreatitis
4.303600E-01
Pancreatitis-vs-NoPancreatitis
8.138200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.321000E-01
Normal-vs-N1
4.365000E-01
N0-vs-N1
8.264600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.382400E-01
Normal-vs-TP53-NonMutant
4.513600E-01
TP53-Mutant-vs-TP53-NonMutant
6.613000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
